november AG

euro adhoc: november AG
Mergers - Acquisitions - Takeovers
november AG assigns peqlab

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Company Information

23.04.2008

Erlangen, 23rd April 2008. With approval of the Supervisory Board november AG assigns its 51% share of PELAB Biotechnologie GmbH with immediate effect. The compensation of EUR 1,500,000.00 will be payable by instalments.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: november AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN:      DE000A0S9N72
WKN:        A0S9N7
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade



Weitere Meldungen: november AG

Das könnte Sie auch interessieren: